Canada · Federal contract register · Contract
Pharmaceutical and other medicinal products — Canada · Federal contract register · Contract: $44.8M contract value ($44,758,560); No competition how it was bought (Advance Contract Award Notice: one supplier named in advance); 2022 contract date (25 October 2022).
Assay record ASY-CA-1WRZK6J1JW · Cite as: Assay Systems, “Pharmaceutical and other medicinal products · National Defence · Emergent BioSolutions Canada Inc.”, https://assay-systems.com/register/ca/contract/c-2024-2025-q4-00010/
| Department | National Defence |
|---|---|
| Supplier | Emergent BioSolutions Canada Inc. |
| Contract date | 25 October 2022 |
| Period | 25 October 2022 – 31 March 2027 |
| Value | $44,758,560 |
| Original value | $9,881,154 |
| Amendments | $24,818,631 |
| Procedure | Non-competitive (Advance Contract Award Notice: one supplier named in advance) |
| Bids received | not stated |
| Economic object code | 1132 |
The department awarded it without a competition. Emergent BioSolutions Canada Inc. took $44,758,560 with no other bid on the table.
Proactive disclosure of contracts over $10,000, Government of Canada, open.canada.ca, under the Open Government Licence – Canada. Where a contract was amended, the page carries the last report filed for it.
Contains information licensed under the Open Government Licence – Canada.Source: Government of Canada proactive disclosure of contracts.